New Delhi: Avantor Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, was recognized with two prestigious awards at the recent Asia-Pacific Biopharma Excellence Awards (ABEA) 2025.
The recognition underscores Avantor’s commitment to providing high-quality biopharma manufacturing solutions, addressing logistics challenges and optimizing supply chain.
Specifically, Avantor was recognized for the ABEA: Best Bioprocessing Supplier Award: Single Use Systems and Best Bioprocessing Supplier Award: Chromatography.
Single-use solutions enhance flexibility and speed in biopharma manufacturing. As the only open-architecture provider, Avantor offers end-to-end design, manufacturing, and logistics support worldwide. With a diverse portfolio of chromatography resins and advanced production technologies, these solutions enable the rapid and scalable delivery of high-quality therapies.
Narayana Rao Rapolu, VP & GM, BPS AMEA, Avantor said, “We are honored by these two awards recognizing Avantor and our team’s contributions to advancing biomanufacturing. As biologics grow more complex, Avantor remains dedicated to providing innovative chromatography and single-use solutions that enhance flexibility, efficiency, and cost-effectiveness globally. Additionally, by leveraging our wide range of chromatography resins, process chemicals, and reagents, our application scientists, and customer support centers are able to provide total solutions that improve process efficiency.”
Rajesh Bhagwat, Director, Strategy & Marketing, BPS AMEA, Avantor said, “Avantor’s expertise in delivering customized, scalable solutions drives innovation in biopharmaceutical manufacturing. Our advanced chromatography resins, including PROchievA and J.T.Baker® Bakerbond®, provide unique selectivity for next-generation therapies across the Asia-Pacific region. This award reinforces our commitment to supporting customers at every stage, from small-scale development to large-scale production.”
The Asia-Pacific Biopharma Excellence Awards (ABEA) recognizes exceptional Asian bioprocessing, biologistic, clinical trials and aseptic fill and finish experts, organizations and technologies. It celebrates outstanding achievements and innovations in the bioprocessing industry across the Asia Pacific region. The awards are judged by a panel of industry experts, and winners are selected based on their contributions to the advancement of the bioprocessing industry.
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans